451 related articles for article (PubMed ID: 15467032)
1. Factors contributing to mammography failure in women aged 40-49 years.
Buist DS; Porter PL; Lehman C; Taplin SH; White E
J Natl Cancer Inst; 2004 Oct; 96(19):1432-40. PubMed ID: 15467032
[TBL] [Abstract][Full Text] [Related]
2. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
[TBL] [Abstract][Full Text] [Related]
3. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
4. Effect of age, breast density, and family history on the sensitivity of first screening mammography.
Kerlikowske K; Grady D; Barclay J; Sickles EA; Ernster V
JAMA; 1996 Jul; 276(1):33-8. PubMed ID: 8667536
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
6. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
7. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer screening by mammography in women aged under 50 years in Japan.
Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
[TBL] [Abstract][Full Text] [Related]
9. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.
Bailey SL; Sigal BM; Plevritis SK
J Natl Cancer Inst; 2010 Aug; 102(16):1263-71. PubMed ID: 20664027
[TBL] [Abstract][Full Text] [Related]
10. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
[TBL] [Abstract][Full Text] [Related]
11. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers.
Porter PL; El-Bastawissi AY; Mandelson MT; Lin MG; Khalid N; Watney EA; Cousens L; White D; Taplin S; White E
J Natl Cancer Inst; 1999 Dec; 91(23):2020-8. PubMed ID: 10580027
[TBL] [Abstract][Full Text] [Related]
12. Biologic characteristics of interval and screen-detected breast cancers.
Gilliland FD; Joste N; Stauber PM; Hunt WC; Rosenberg R; Redlich G; Key CR
J Natl Cancer Inst; 2000 May; 92(9):743-9. PubMed ID: 10793111
[TBL] [Abstract][Full Text] [Related]
13. Mammographic changes resulting from benign breast surgery impair breast cancer detection at screening mammography.
van Breest Smallenburg V; Duijm LE; Voogd AC; Jansen FH; Louwman MW
Eur J Cancer; 2012 Sep; 48(14):2097-103. PubMed ID: 22513229
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.
Cuzick J; Warwick J; Pinney E; Duffy SW; Cawthorn S; Howell A; Forbes JF; Warren RM
J Natl Cancer Inst; 2011 May; 103(9):744-52. PubMed ID: 21483019
[TBL] [Abstract][Full Text] [Related]
15. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.
Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R;
J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years.
Thurfjell EL; Lindgren JA
Radiology; 1996 Nov; 201(2):421-6. PubMed ID: 8888234
[TBL] [Abstract][Full Text] [Related]
18. Screening mammography: clinical image quality and the risk of interval breast cancer.
Taplin SH; Rutter CM; Finder C; Mandelson MT; Houn F; White E
AJR Am J Roentgenol; 2002 Apr; 178(4):797-803. PubMed ID: 11906848
[TBL] [Abstract][Full Text] [Related]
19. Screening mammography: value in women 35-39 years old.
Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
[TBL] [Abstract][Full Text] [Related]
20. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.
Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
